Lannett's Board Of Directors Initiates CEO Search
CEO Arthur Bedrosian to Step Down Upon Naming of a Successor
Company Submits 505(b)(2) New Drug Application for Its Proprietary Anesthetic Product, Cocaine Hydrochloride (HCl) Topical Solution
PHILADELPHIA, Sept. 25, 2017 -- (Healthcare Sales & Marke... Biopharmaceuticals, Generics, Personnel, FDA Lannett Company, Cocaine HCl
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news